ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Invicta Diagnostic Limited reported changes to its leadership and audit team, including a director's re-appointment, a designation change, and a new secretarial auditor.
Invicta Diagnostic Limited conducted its 3rd Annual General Meeting on September 19, 2026. The proceedings detailed company operations and future financial targets.
Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.
Invicta's subsidiaries commenced operations at two diagnostic centres in Shegaon and Pune. Investment is Rs. 70 lakhs for CT scan and pathology services.
Invicta Diagnostic approved the notice for its 3rd Annual General Meeting scheduled for 19th September 2026, alongside adoption of financial reports and director appointments.
Invicta Diagnostic Limited is selling its associate entity, MSCRIBEIT INFOTECH LLP, for a cash consideration of Rs. 50,000. The transaction is expected to conclude by March 2027.
Invicta Diagnostic Limited announced the resignations of Executive Director Rohit Prakash Srivastava and Manager Konica Rohit Srivastava. Additionally, Director Sanket Vinod Jain was redesignated as Executive Director.
Invicta Diagnostic Limited announced management changes, including the appointment of Dr. Sanket Vinod Jain as Managing Director, and the divestment of its stake in MSCRIBEIT Infotech LLP.
Invicta Diagnostic Limited has scheduled a board meeting on July 29, 2026. The agenda includes board appointments and the proposed sale of its stake in MSCRIBEIT INFOTECH LLP.
Invicta Diagnostic Limited reported a management change in its subsidiary, Porteus Pathogenius LLP, involving the appointment of Mayur Shivdas Kasat following Vishwajeet Arvind Burungale's stake sale.
Invicta Diagnostic Limited informed the exchange of a partner change in its step-down subsidiary, Porteus Pathogenius LLP. Mr. Mayur Shivdas Kasat has been inducted as a partner.